Insights

More with analytics

Trends in Telco PR: 5G in the Media

Telecommunications companies aiming to leverage 5G are currently in the process of positioning themselves as the top players in the new field. Their PR priority is to be perceived as first-movers, innovators, critical for digital transformation and fundamental for IoT...

read more

Meat Alternatives: Cooking Up a Market Disruption

The meat substitutes market is gaining momentum, driven by lively debates in the media, and many big food companies want to take a bite. Analysing the media coverage, we found that the most widely discussed topics are ethics and animal rights, research, regulation and...

read more

Cannabis-Infused Drinks: Exploring the New Beverage Trend

As the global soft-drink and alcohol consumption slows down, a growing number of companies think of cannabis beverages as a new growth vector. However, marketing cannabis-infused products could bring some reputational risks. An effective PR campaign can’t afford to...

read more

Financial Crisis Anniversary: The Media’s Verdicts

Communication professionals working in finance could draw important lessons from the recent coverage of the financial crisis’ 10th anniversary – it encapsulates the PR problems that have been plaguing the industry for the last decade. Employing our media analytics...

read more

Pharma and Mental Health: Reputation Challenges

Analysing the mental health coverage, we concluded that while the awareness of mental health issues is increasing, pharma’s reputation in this area lags behind: the number of mental health-related articles which mention pharma companies is very limited. In addition,...

read more

Alzheimer’s in the Media: The Power of Influencers

Due to the 99.6% failure rate of new Alzheimer’s drugs, scepticism is the default attitude in the media coverage of everything around the increasingly occurring disease. To tackle the inevitable reputation hurdles, communication professionals should take advantage...

read more

The Future of Pharma? Mapping the Gene Therapy Trend

In their latest study on the pharma market, intelligence provider Evaluate pointed out that the development and commercialisation of gene and cell therapies are turning into a powerful engine of value creation for pharma companies. The launch of these novel therapies...

read more

Need to know more about analytics?

Get our latest insights and valuable content delivered every couple of weeks directly to your inbox.

Subscribe to our newsletter

By submitting this form, you are confirming you have read and agree to our Privacy Policy.

Pin It on Pinterest